Michael James Bodkin
Research Subjects
Michael James Bodkin has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
David Evans
Department of Medicinal Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Erl Wood Manor, Surrey GU20 6PH, UK
1 shared publicationDavid Thorner
Department of Medicinal Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Erl Wood Manor, Surrey GU20 6PH, UK
1 shared publication- George Papadatos
European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, UK
1 shared publication John Richard Morphy
Department of Medicinal Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Erl Wood Manor, Surrey GU20 6PH, UK
1 shared publicationNikolas Fechner
Department of Medicinal Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Erl Wood Manor, Surrey GU20 6PH, UK
1 shared publicationSuzanne Clare Brewerton
Department of Medicinal Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Erl Wood Manor, Surrey GU20 6PH, UK
1 shared publication
Latest Publications
- Open Access
- 20 December 2012
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 29 (4) , 523-524
ChEMBLSpace—a graphical explorer of the chemogenomic space covered by the ChEMBL database
Motivation: The ChEMBLSpace graphical explorer enables the identification of compounds from the ChEMBL database, which exhibit a desirable polypharmacology profile. This profile can be predefined or created iteratively, and the tool can be extended to other data sources. Contact:m.bodkin@lilly.com
- 20 December 2012
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 29 (4) , 523-524
Open AccessChEMBLSpace—a graphical explorer of the chemogenomic space covered by the ChEMBL database
Motivation: The ChEMBLSpace graphical explorer enables the identification of compounds from the ChEMBL database, which exhibit a desirable polypharmacology profile. This profile can be predefined or created iteratively, and the tool can be extended to other data sources. Contact:m.bodkin@lilly.com
- 22 October 2012
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 4 (15) , 1889-1891
Why Don’t We See A Greater Uptake Of Computational Chemistry Approaches By The Medicinal Chemistry Community?
- 22 October 2012
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 4 (15) , 1889-1891
Why Don’t We See A Greater Uptake Of Computational Chemistry Approaches By The Medicinal Chemistry Community?